Follow $IVW

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IVW by email
ARCX · IVW
+0.67% · +$0.9200 · Vol 1.1M
After hours · updated 18:30:00 ET
IVW

iShares S&P 500 Growth ETF

$138.80
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for IVW until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is IVW moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IVW catalysts
About iShares S&P 500 Growth ETF
Listed since
2000
Country
US
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$138.76
Day high
$139.22
Day low
$138.10
Previous close
$137.88
52W high
$142.54
-2.62% from high
52W low
$108.71
89% of range
Beta
1.46
Shares out
548.2M
Volume
1.1M
0.88× rel vol
Avg volume
1.3M
VWAP
$138.62
Price history computed in-house
1W
-0.63%
1M
+4.49%
3M
+0.35%
1Y
+20.96%
YTD
+12.61%
SMA 50 $137.14 · above
SMA 200 $127.73 · above
52W position 89%

IVW overview

Financials
Company financial statements are not applicable for IVW.
Loading IVW Form 4 filings
Public disclosures

Congress activity in IVW

Federal contracts

IVW contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IVW in this window.
Lobbying spend

IVW lobbying filings, year to date.

Registered lobbying filings matched to iShares S&P 500 Growth ETF.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IVW in this window.
Loading news for IVW
Analyst ratings
Sovereign unlock shows live analyst consensus for IVW.
Options
Sovereign unlock shows live options positioning for IVW.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.